LEVERAGE SHARES -1X APPLE (APLS:NASDAQ)
$41.03 -0.03 (-0.0731%)
Analysed LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) News Sources
Biogen Q1 Earnings: Can New Launches Offset Declining MS Franchise?
24-04-2026
yahoo.com
Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Should You Buy?
29-04-2026
yahoo.com
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: Should You Buy?
01-05-2026
yahoo.com
Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates
07-05-2026
yahoo.com
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics
07-05-2026
yahoo.com
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
07-05-2026
yahoo.com
Biogen Completes Acquisition of Apellis Pharmaceuticals
14-05-2026
yahoo.com
Biogen completes $5.3B Apellis Pharmaceuticals acquisition
15-05-2026
qz.com
Biogen’s Apellis Deal And Alzheimer’s Trial Shift Focus Beyond Price
18-05-2026
yahoo.com
Biogen Stock Slides After Trial Miss, But Analysts Stay Bullish
22-05-2026
marketbeat.com
What is the current price of LEVERAGE SHARES -1X APPLE (APLS:NASDAQ)?
The current price of LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) is $41.03.
LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) absolute price change since previous trading day?
The absolute price change of LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) since the previous trading day is $-0.03.
LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) percentage price change since previous trading day?
The percentage price change of LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) since the previous trading day is -0.0731%.
What is the most recent average sentiment score for LEVERAGE SHARES -1X APPLE (APLS:NASDAQ)?
The most recent average sentiment score for LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for LEVERAGE SHARES -1X APPLE (APLS:NASDAQ)?
The most recent sentiment for LEVERAGE SHARES -1X APPLE (APLS:NASDAQ) is .
SEC-8K** Filing Available For LEVERAGE SHARES -1X APPLE (APLS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.